Fintel · Aug 19, 2026
NYSE · MD
Pediatrix Medical Group, Inc.
Healthcare · Medical - Care Facilities
$26.61
Down-$0.36 (-1.35%)
Updated Aug 31, 2026, 7:18 PM
SID Score
7.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.9B
- P/E ratio
- 11.54
- Dividend yield
- 0.00%
- 52-week range
- $19.06 – $27.94
- Volume
- 706.85K
- Avg. volume
- 931.29K
Price performance
MD price history
1M range · 20 trading sessions · Daily adjusted prices
MD closed at $26.61 after 20 trading sessions, up 1.37% for the selected period.
- Last close
- $26.61
- Period change
- +1.37%
- Period low
- $24.71
- Period high
- $27.08
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $26.92 | $27.06 | $26.4131 | $26.61 | 706.85K |
| Aug 27, 2026 | $26.79 | $26.9163 | $26.6301 | $26.80 | 544.49K |
| Aug 26, 2026 | $26.93 | $27.26 | $26.70 | $26.95 | 528.16K |
| Aug 25, 2026 | $27.10 | $27.10 | $26.5573 | $26.99 | 507.7K |
| Aug 24, 2026 | $26.66 | $26.99 | $26.36 | $26.60 | 681.71K |
| Aug 21, 2026 | $26.20 | $26.68 | $26.00 | $26.57 | 956.15K |
| Aug 20, 2026 | $26.45 | $27.00 | $26.06 | $26.22 | 869.78K |
| Aug 19, 2026 | $26.145 | $26.44 | $25.15 | $26.22 | 1.35M |
| Aug 18, 2026 | $26.54 | $27.14 | $26.45 | $26.56 | 943.16K |
| Aug 17, 2026 | $26.39 | $26.64 | $25.87 | $26.34 | 613.14K |
| Aug 14, 2026 | $26.25 | $26.81 | $26.14 | $26.61 | 607.14K |
| Aug 13, 2026 | $26.70 | $26.97 | $26.04 | $26.37 | 719.45K |
| Aug 12, 2026 | $26.00 | $26.60 | $26.00 | $26.50 | 630.99K |
| Aug 11, 2026 | $26.22 | $26.7399 | $26.10 | $26.14 | 673.68K |
| Aug 10, 2026 | $26.68 | $26.9389 | $25.48 | $26.08 | 862.57K |
| Aug 7, 2026 | $26.39 | $27.329 | $26.39 | $27.08 | 898.46K |
| Aug 6, 2026 | $25.63 | $26.71 | $25.63 | $26.51 | 1.07M |
| Aug 5, 2026 | $24.94 | $26.44 | $24.94 | $25.99 | 1.5M |
| Aug 4, 2026 | $23.555 | $26.60 | $22.60 | $24.71 | 1.55M |
| Aug 3, 2026 | $26.70 | $27.30 | $26.195 | $26.25 | 720.68K |
Latest MD news
The latest Smart Investors Daily articles mentioning MD.
Stock researchCompany · Overview
MD research
Overview
Company profile and research snapshot.
Company profile
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $23.50
- Implied upside
- —
- Analysts
- 15
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 19, 2026 | Jefferies | Hold | — |
| Aug 6, 2026 | UBS | Neutral | — |
| Jul 14, 2026 | Truist Securities | Hold | — |
| May 12, 2026 | UBS | Neutral | — |
| Apr 13, 2026 | Truist Securities | Hold | — |
News briefing
No generated briefing is available yet.
Benzinga · Aug 19, 2026
Jefferies Downgrades Pediatrix Medical Group to Hold, Raises Price Target to $28
Jefferies analyst Jack Slevin downgrades Pediatrix Medical Group (NYSE:MD) from Buy to Hold and raises the price target from $27 to $28.
ChartMill · Aug 15, 2026
Pediatrix Medical Group (NYSE:MD): A Value Stock with a Clear Margin of Safety
Pediatrix Medical Group (MD) offers strong value with a P/E of 11.9, solid profitability, and manageable debt—an overlooked pick for patient investors.
Benzinga · Aug 6, 2026
UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $28
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $25 to $28.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.

